| JXHB2400032 | PF-07220060 | ATIRMOCICLIB | Active ingredient | Chemical Drugs(1) | Supplementary Application | 2024-01-31 | | Pfizer Inc | | | view |
| JXHL2101250 | PF-07220060 | ATIRMOCICLIB | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2021-11-23 | | Pfizer Inc;Pfizer Investment Co Ltd | | | view |
| JXHL2101249 | PF-07220060 | ATIRMOCICLIB | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2021-11-23 | | Pfizer Inc;Pfizer Investment Co Ltd | | | view |
| JXHL2400058 | PF-07220060 | ATIRMOCICLIB | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2024-03-04 | | Pfizer Inc;Pfizer Investment Co Ltd | | | view |
| JXHB2300031 | PF-07220060 | ATIRMOCICLIB | Active ingredient | Chemical Drugs(1) | Supplementary Application | 2023-02-11 | | Pfizer Inc | | | view |
| JXHL2400298 | PF-07220060 | ATIRMOCICLIB | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2024-12-21 | | Pfizer Inc;Pfizer Investment Co Ltd | | | view |
| JXHL2400010 | PF-07220060 | ATIRMOCICLIB | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2024-01-11 | | Pfizer Inc;Pfizer Investment Co Ltd | | | view |
| JXHB2200042 | PF-07220060 | ATIRMOCICLIB | Active ingredient | Chemical Drugs | Supplementary Application | 2022-03-31 | | Pfizer Inc | | | view |
| JXHL2400059 | PF-07220060 | ATIRMOCICLIB | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2024-03-04 | | Pfizer Inc;Pfizer Investment Co Ltd | | | view |
| JXHL2200265 | PF-07220060 | ATIRMOCICLIB | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2022-08-31 | | Pfizer Inc;Pfizer Investment Co Ltd | | | view |
| JXHL2400297 | PF-07220060 | ATIRMOCICLIB | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2024-12-21 | | Pfizer Inc;Pfizer Investment Co Ltd | | | view |
| JXHL2300026 | PF-07220060 | ATIRMOCICLIB | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2023-02-17 | | Pfizer Inc;Pfizer Investment Co Ltd | | | view |
| JXHB2200041 | PF-07220060 | ATIRMOCICLIB | Active ingredient | Chemical Drugs | Supplementary Application | 2022-03-31 | | Pfizer Inc | | | view |
| JXHL2400057 | PF-07220060 | ATIRMOCICLIB | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2024-03-04 | | Pfizer Inc;Pfizer Investment Co Ltd | | | view |
| JXHB2400188 | PF-07220060 | ATIRMOCICLIB | Active ingredient | Chemical Drugs(1) | Supplementary Application | 2024-11-14 | | Pfizer Ltd;Pfizer Inc | | | view |
| JXHL2101251 | PF-07220060 | ATIRMOCICLIB | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2021-11-23 | | Pfizer Inc;Pfizer Investment Co Ltd | | | view |
| JXHL2300027 | PF-07220060 | ATIRMOCICLIB | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2023-02-17 | | Pfizer Inc;Pfizer Investment Co Ltd | | | view |
| JXHB2200096 | PF-07220060 | ATIRMOCICLIB | Active ingredient | Chemical Drugs(1) | Supplementary Application | 2022-07-14 | | Pfizer Inc | | | view |
| JXHB2400030 | PF-07220060 | ATIRMOCICLIB | Active ingredient | Chemical Drugs(1) | Supplementary Application | 2024-01-31 | | Pfizer Inc | | | view |
| JXHB2400190 | PF-07220060 | ATIRMOCICLIB | Active ingredient | Chemical Drugs(1) | Supplementary Application | 2024-11-14 | | Pfizer Inc | | | view |
